AMN Healthcare price target lowered to $27 from $41 at Jefferies

Jefferies lowered the firm’s price target on AMN Healthcare (AMN) to $27 from $41 and keeps a Hold rating on the shares as the analyst took over coverage of the stock. Q3 was “a solid print,” but the Q4 guidance disappointed, particularly when looking at a low-to-mid $50M quarterly EBITDA run-rate after backing out a strike benefit, the analyst tells investors.